DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023 SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for...

Elsevier Publishes Five New Neuroscience Books and Atlases WALTHAM, MA--(Marketwired - October 15, 2015) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of five new...